Seeking Alpha

Adam Feuerstein at The Street helpfully provides a list of 31 drugs that are awaiting FDA...

Adam Feuerstein at The Street helpfully provides a list of 31 drugs that are awaiting FDA approval decisions between now and April, and the relevant dates. The closest D-Day is for Gilead (GILD -1.1%) on Monday next week, when the FDA will decide on the firm's Quad for HIV treatment, which combines four drugs into a single, once-daily pill.
From other sites
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs